Ayca Ece Nezir - Publications

Affiliations: 
Yeditepe University, Istanbul Turkey 
Area:
Molecular Cell Biology

6 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2024 Bolat ZB, Nezir AE, Saka OM, Zemheri IE, Gülyüz S, Özköse UU, Yilmaz Ö, Bozkir A, Telci D, Şahin F. Delivery of proapoptotic gene in Peptide-18-targeted Poly(2-oxazoline)-DOPE nanoliposomes for breast cancer models. Turkish Journal of Biology = Turk Biyoloji Dergisi. 48: 299-307. PMID 39474037 DOI: 10.55730/1300-0152.2706  0.661
2024 Nezir AE, Bolat ZB, Saka OM, Zemheri IE, Gülyüz S, Özköse UU, Yilmaz Ö, Bozkir A, Şahin F, Telci D. PEtOx-DOPE nanoliposomes functionalized with peptide 563 in targeted delivery to prostate cancer. Turkish Journal of Biology = Turk Biyoloji Dergisi. 48: 174-181. PMID 39050711 DOI: 10.55730/1300-0152.2693  0.656
2023 Nezir AE, Bolat ZB, Ozturk N, Kocak P, Zemheri E, Gulyuz S, Ozkose UU, Yilmaz O, Vural I, Bozkır A, Sahin F, Telci D. Targeting prostate cancer with docetaxel-loaded peptide 563-conjugated PEtOx-co-PEI-b-PCL polymeric micelle nanocarriers. Amino Acids. PMID 37318626 DOI: 10.1007/s00726-023-03292-3  0.679
2021 Bolat ZB, Nezir AE, Devrim B, Zemheri E, Gulyuz S, Ozkose UU, Yilmaz O, Bozkir A, Telci D, Sahin F. Delivery of doxorubicin loaded P18 conjugated-poly(2-ethyl-oxazoline)-DOPE nanoliposomes for targeted therapy of breast cancer. Toxicology and Applied Pharmacology. 428: 115671. PMID 34391753 DOI: 10.1016/j.taap.2021.115671  0.66
2021 Nezir AE, Khalily MP, Gulyuz S, Ozcubukcu S, Küçükgüzel ŞG, Yilmaz O, Telci D. Synthesis and evaluation of tumor-homing peptides for targeting prostate cancer. Amino Acids. PMID 33846842 DOI: 10.1007/s00726-021-02971-3  0.671
2019 Nezir AE, Ulukan B, Telci D. Transglutaminase 2: The Maestro of the Oncogenic Mediators in Renal Cell Carcinoma. Medical Sciences (Basel, Switzerland). 7. PMID 30736384 DOI: 10.3390/Medsci7020024  0.553
Show low-probability matches.